(ASCO Abst 1175,2003) To decrease the recurrent rate at extrahepatic sites and improve prognosis we instituted PMC in combination with hepatic arterial 5FU infusion, continuous venous 5FU infusion and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results